These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33548257)

  • 1. Morbidity and Disability in Juvenile Localized Scleroderma: The Case for Early Recognition and Systemic Immunosuppressive Treatment.
    Li SC; O'Neil KM; Higgins GC
    J Pediatr; 2021 Jul; 234():245-256.e2. PubMed ID: 33548257
    [No Abstract]   [Full Text] [Related]  

  • 2. Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
    Li SC
    Pediatr Clin North Am; 2018 Aug; 65(4):757-781. PubMed ID: 30031497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurologic manifestations of localized scleroderma: a case report and literature review.
    Kister I; Inglese M; Laxer RM; Herbert J
    Neurology; 2008 Nov; 71(19):1538-45. PubMed ID: 18981376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic sclerosis and localized scleroderma in childhood.
    Zulian F
    Rheum Dis Clin North Am; 2008 Feb; 34(1):239-55; ix. PubMed ID: 18329543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile localised scleroderma: a retrospective review of response to systemic treatment.
    Cox D; O' Regan G; Collins S; Byrne A; Irvine A; Watson R
    Ir J Med Sci; 2008 Dec; 177(4):343-6. PubMed ID: 18941862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleroderma in childhood.
    Kornreich HK; King KK; Bernstein BH; Singsen BH; Hanson V
    Arthritis Rheum; 1977 Mar; 20(2 Suppl):343-50. PubMed ID: 263911
    [No Abstract]   [Full Text] [Related]  

  • 7. A Case of Pansclerotic Morphea Treated With Tocilizumab.
    Zhang A; Nocton J; Chiu Y
    JAMA Dermatol; 2019 Mar; 155(3):388-389. PubMed ID: 30649148
    [No Abstract]   [Full Text] [Related]  

  • 8. New developments in juvenile systemic and localized scleroderma.
    Foeldvari I
    Rheum Dis Clin North Am; 2013 Nov; 39(4):905-20. PubMed ID: 24182860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleroderma in children: an update.
    Zulian F; Cuffaro G; Sperotto F
    Curr Opin Rheumatol; 2013 Sep; 25(5):643-50. PubMed ID: 23912318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphea or juvenile localised scleroderma: Case report].
    Strickler A; Gallo S; Jaramillo P; de Toro G
    Rev Chil Pediatr; 2016; 87(4):279-83. PubMed ID: 26976080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease.
    Hedrich CM; Fiebig B; Hahn G; Suttorp M; Gahr M
    Clin Pediatr (Phila); 2011 Jul; 50(7):604-14. PubMed ID: 21525084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Practical Approach to Juvenile Dermatomyositis and Juvenile Scleroderma.
    McCann LJ; Pain CE
    Indian J Pediatr; 2016 Feb; 83(2):163-71. PubMed ID: 26489640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleroderma in children.
    Zulian F
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):576-595. PubMed ID: 29773274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review.
    Martini G; Fadanelli G; Agazzi A; Vittadello F; Meneghel A; Zulian F
    Autoimmun Rev; 2018 Jul; 17(7):727-734. PubMed ID: 29729451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Localized scleroderma in childhood].
    Domenici R; Simoni F; Camici G
    Pediatr Med Chir; 1988; 10(3):297-302. PubMed ID: 3186514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pesticide-induced scleroderma and early intensive immunosuppressive treatment.
    Sozeri B; Gulez N; Aksu G; Kutukculer N; Akalın T; Kandiloglu G
    Arch Environ Occup Health; 2012; 67(1):43-7. PubMed ID: 22315935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful combination treatment of a patient with progressive juvenile localized scleroderma (morphea) using imatinib, corticosteroids, and methotrexate.
    Inamo Y; Ochiai T
    Pediatr Dermatol; 2013; 30(6):e191-3. PubMed ID: 23025697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate in Linear Scleroderma: Long-Term Efficacy in Fifty Children From a Single Pediatric Rheumatology Center.
    Fadanelli G; Agazzi A; Vittadello F; Meneghel A; Zulian F; Martini G
    Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1259-1263. PubMed ID: 32433808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disabling pansclerotic morphea of childhood--unusual case and management challenges.
    Forsea AM; Cretu AN; Ionescu R; Giurcaneanu C
    J Med Life; 2008; 1(3):348-54. PubMed ID: 20108512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil.
    Martini G; Ramanan AV; Falcini F; Girschick H; Goldsmith DP; Zulian F
    Rheumatology (Oxford); 2009 Nov; 48(11):1410-3. PubMed ID: 19713439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.